Optical Sensors acquires technology, renamed Vasamed:
This article was originally published in Clinica
Minneapolis, Minnesota-based haemodynamic monitoring technology firm Optical Sensors has changed its name to Vasamed. The new name "better reflects the suite of products that we currently have and will be introducing for haemodynamic monitoring", said president and CEO Paulita LaPlante. The company, which developed the CapnoProbe sensor system to measure sublingual CO(2), has also acquired from an unnamed private company an FDA-cleared impedance cardiography system for noninvasive cardiac output monitoring. It intends to refine the software and other features and launch the product in the next few months.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.